"Receptors, IgG" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor).
| Descriptor ID |
D017452
|
| MeSH Number(s) |
D12.776.543.750.705.871.300
|
| Concept/Terms |
Receptors, IgG- Receptors, IgG
- IgG Receptors
- gamma Fc Receptors
- Fc gamma Receptors
- gamma Receptors, Fc
- Receptors, Fc gamma
- Immunoglobulin G Receptor
- Receptor, Immunoglobulin G
- Fc Receptors, gamma
- Receptors, gamma Fc
CD32 Antigens- CD32 Antigens
- CD 32 Antigens
- Antigens, CD 32
- Fc gamma RII
- gamma RII, Fc
- Antigens, CD32
CD64 Antigens- CD64 Antigens
- CD 64 Antigens
- Antigens, CD 64
- Fc gamma RI
- gamma RI, Fc
- Antigens, CD64
Antigens, CD16- Antigens, CD16
- Fc gamma RIII
- gamma RIII, Fc
- CD 16 Antigens
- Antigens, CD 16
- CD16 Antigens
|
Below are MeSH descriptors whose meaning is more general than "Receptors, IgG".
Below are MeSH descriptors whose meaning is more specific than "Receptors, IgG".
This graph shows the total number of publications written about "Receptors, IgG" by people in this website by year, and whether "Receptors, IgG" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2002 | 1 | 2 | 3 |
| 2005 | 1 | 3 | 4 |
| 2006 | 1 | 3 | 4 |
| 2007 | 1 | 1 | 2 |
| 2008 | 2 | 2 | 4 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 2 | 2 |
| 2011 | 1 | 2 | 3 |
| 2012 | 0 | 3 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 3 | 2 | 5 |
| 2018 | 0 | 3 | 3 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 3 | 4 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 3 | 4 |
| 2025 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, IgG" by people in Profiles.
-
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19. JCI Insight. 2025 Jul 08; 10(13).
-
Fc?R binding differentially contributes to protection by two human monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein. Sci Transl Med. 2025 Apr 23; 17(795):eadk6745.
-
Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding. Cancer Cell. 2025 Jan 13; 43(1):122-143.e8.
-
NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children. J Immunol. 2024 Nov 15; 213(10):1452-1466.
-
B cells drive neuropathic pain-related behaviors in mice through IgG-Fc gamma receptor signaling. Sci Transl Med. 2024 09 25; 16(766):eadj1277.
-
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fc? receptors during acute SHIVAD8-EO infection. Nat Commun. 2024 Aug 29; 15(1):7461.
-
Using machine learning to dissect host kinases required for Leishmania internalization and development. Mol Biochem Parasitol. 2024 12; 260:111651.
-
Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis. Cancer Immunol Res. 2024 Aug 01; 12(8):964-987.
-
Mixed IgG Fc immune complexes exhibit blended binding profiles and refine FcR affinity estimates. Cell Rep. 2023 07 25; 42(7):112734.
-
Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial. Cancer Immunol Immunother. 2023 Jul; 72(7):2099-2111.